<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-03-14T23:44:59Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/38000" metadataPrefix="oai_dc">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/38000</identifier><datestamp>2025-02-21T07:51:56Z</datestamp><setSpec>com_10324_23459</setSpec><setSpec>com_10324_954</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_23462</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
<dc:title>Usefulness of Spectral Analysis of Respiratory Rate Variability to Help in Pediatric Sleep Apnea-Hypopnea Syndrome Diagnosis</dc:title>
<dc:title>41st Annual International Conference of the IEEE Engineering in Medicine and Biology Society</dc:title>
<dc:creator>Barroso García, Verónica</dc:creator>
<dc:creator>Gutierrez Tobal, Gonzalo César</dc:creator>
<dc:creator>Kheirandish Gozal, Leila</dc:creator>
<dc:creator>Álvarez González, Daniel</dc:creator>
<dc:creator>Vaquerizo Villar, Fernando</dc:creator>
<dc:creator>Campo Matias, Félix del</dc:creator>
<dc:creator>Gozal, David</dc:creator>
<dc:creator>Hornero Sánchez, Roberto</dc:creator>
<dc:description>Producción Científica</dc:description>
<dc:description>The sleep apnea-hypopnea syndrome (SAHS) is a&#xd;
chronic respiratory disorder of high prevalence among children&#xd;
(up to 4%). Nocturnal polysomnography (PSG) is the gold&#xd;
standard method to diagnose SAHS, which is a complex,&#xd;
expensive, and time-consuming test. Consequently, alternative&#xd;
simplified methods are demanded. We propose the analysis of&#xd;
the respiratory rate variability (RRV) signal, directly obtained&#xd;
from the airflow (AF) signals. The aim of our study is to&#xd;
evaluate the usefulness of the spectral information obtained&#xd;
from RRV in the diagnosis of pediatric SAHS. A database&#xd;
composed of 946 AF and blood oxygen saturation (SpO2)&#xd;
recordings from children between 0 and 13 years old was used.&#xd;
Our database was divided into four severity groups according&#xd;
to the apnea-hipopnea index (AHI): no-SAHS (AHI &lt; 1&#xd;
events/h), mild (1 events/h ≤ AHI &lt; 5 events/h), moderate (5&#xd;
events/h ≤ AHI &lt; 10 events/h), and severe SAHS (AHI ≥ 10&#xd;
events/h). RRV and 3% oxygen desaturation index (ODI3) were&#xd;
obtained from AF and SpO2 recordings, respectively. A&#xd;
spectral band of interest was determined (0.09–0.20 Hz.) and a&#xd;
total of 12 spectral features were extracted. Nine of these&#xd;
features showed statistically significant differences (p-value &lt;&#xd;
0.05) among the four severity groups. The spectral features&#xd;
from RRV along with ODI3 were used as inputs to binary&#xd;
logistic regression (LR) classifiers. The diagnostic performance&#xd;
of LR models were evaluated for the AHI cut-off points of 1, 5,&#xd;
and 10 e/h, achieving 66.5%, 84.0%, and 88.5% accuracy,&#xd;
respectively. These results outperformed those obtained by&#xd;
single ODI3. The joint use of the spectral information from&#xd;
RRV and ODI3 achieved a high diagnostic capability in the&#xd;
most severely-affected children, thus showing their&#xd;
complementarity. These results suggest that the information&#xd;
contained in RRV spectrum together with ODI3 is useful to help&#xd;
identify moderate-to-severe SAHS.</dc:description>
<dc:description>This work was supported by 'Ministerio de Ciencia, Innovación y Universidades' and ‘European Regional Development Fund (FEDER)’ under projects DPI2017-84280-R and RTC-2017-6516-1, and by ‘European Commission’ and ‘FEDER’ under project ‘POCTEP 0378_AD_EEGWA_2_P’. V. Barroso-García was in a receipt of a ‘Ayuda para financiar la contratación predoctoral de personal investigador’ grant from the Consejería de Educación de la Junta de Castilla y León and the European Social Fund. F. Vaquerizo-Villar was in receipt of a ‘Ayuda para contratos predoctorales para la Formación de Profesorado Universitario (FPU)’ grant from the Ministerio de Educación, Cultura y Deporte (FPU16/02938). L. Kheirandish-Gozal and D. Gozal were supported by National Institutes of Health (NIH) grant HL130984. V. Barroso-García, G. C. Gutiérrez-Tobal, F. Vaquerizo-Villar, and R. Hornero, are with the Biomedical Engineering Group, Universidad de Valladolid, Spain (e-mail: veronica.barroso@gib.tel.uva.es). D. Álvarez and F. del Campo are with the Hospital Universitario Río Hortega of Valladolid, Spain (e-mail: fsas@telefonica.net). L. Kheirandish-Gozal and D. Gozal are with the Department of Child Health, The University of Missouri School of Medicine, Columbia, Missouri, USA (email: gozald@health.missouri.edu).</dc:description>
<dc:date>2019-09-18T10:35:25Z</dc:date>
<dc:date>2019-09-18T10:35:25Z</dc:date>
<dc:date>2019</dc:date>
<dc:type>info:eu-repo/semantics/conferenceObject</dc:type>
<dc:type>info:eu-repo/semantics/submittedVersion</dc:type>
<dc:identifier>978-1-5386-1311-5</dc:identifier>
<dc:identifier>http://uvadoc.uva.es/handle/10324/38000</dc:identifier>
<dc:language>eng</dc:language>
<dc:rights>info:eu-repo/semantics/restrictedAccess</dc:rights>
<dc:format>application/pdf</dc:format>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>